The Impact of Hidradenitis Suppurativa on Families
Iltefat Hamzavi, MD, discusses the importance of support groups and other helpful resources for families and caregivers of patients with hidradenitis suppurativa and provides closing thoughts for clinical providers.
Hidradenitis Suppurativa: Addressing the Psychosocial Impact and Hospitalization Rate
Dr Hamzavi discusses how clinicians can address the psychosocial impact of hidradenitis suppurativa on patients and the rate of hospitalization.
Comorbidities and Coordinating Care Between Specialists in Hidradenitis Suppurativa
Iltefat Hamzavi, MD, outlines comorbidities associated with hidradenitis suppurativa and discusses best practices for coordinating care between specialists.
Overview of the Hurley Staging System for Hidradenitis Suppurativa
An expert on hidradenitis suppurativa describes the characteristics for each of the 3 stages in the Hurley staging system and how they inform treatment decisions.
Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient
A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.
The Pathophysiology of Hidradenitis Suppurativa
Iltefat Hamzavi, MD, describes the pathophysiology of hidradenitis suppurativa and associated comorbidities that are commonly seen in patients.
Epidemiology and Impact of Hidradenitis Suppurativa
An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.
Signs and Symptoms of Hidradenitis Suppurativa (HS)
Iltefat Hamzavi, MD, introduces a discussion on the treatment of hidradenitis suppurativa with an overview of the signs and symptoms of the disease.
